Few Adults Talk to Providers About BP Risks of OTC Pain Relievers
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, Nov. 7, 2023 -- Only about 30 percent of U.S. adults have spoken with their health care professional about the adverse effects some over-the-counter pain relievers can have on blood pressure, according to a poll released by the American Heart Association.
The online poll included approximately 3,000 U.S. adults. According to the results of the survey, nearly 50 percent of respondents took medication for pain once a week or more. Of all age groups, adults aged 45 to 54 years reported taking over-the-counter pain relievers most frequently. Of respondents who had been diagnosed with high blood pressure, White and Asian adults (40 percent) were significantly less likely than Black (54.2 percent) and Hispanic (54.1 percent) adults to have ever discussed the effect some pain relievers have on blood pressure with a health care professional.
"It's paramount that people who have high blood pressure, or are at risk for it, understand the effects associated with some over-the-counter pain relievers," Mitchell S.V. Elkind, M.D., chief clinical science officer of the American Heart Association, said in a statement. "Some over-the-counter pain relievers are safer than others. A conversation with a health care professional about pain relief options is essential to preventing and managing high blood pressure."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-11-08 07:08
Read more

- Prehospital Blood Test Can Rapidly Differentiate Stroke Types
- GLP-1 RAs Tied to Higher Thyroid Cancer Risk in First Year of Treatment
- FDA Approves Leqembi (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
- Epstein-Barr Virus Might Help Trigger Cancer After Kidney Transplant
- Nutrition Label Policies May Have Negative Impact on People With Eating Disorders
- AI Virtual Therapists Could Improve Mental Health Care, Studies Find
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions